LivsMed

Based in South Korea, LivsMed operates as a medical device company, focusing on the development of advanced surgical instruments and therapeutic devices that enhance healthcare delivery and improve patient outcomes. LivsMed, founded in 2011 in Seongnam, South Korea, specializes in the production of medical devices. The company has successfully completed 14 deals and recently raised KRW 135. 85 billion in an IPO, selling 2.

47 million shares at KRW 55,000 apiece, within the expected KRW 44,000-55,000 price range on the KOSDAQ. Jung-ju Lee serves as both the founder and CEO, bringing a wealth of experience from previous entrepreneurial ventures. LivsMed specializes in advanced medical devices designed primarily for healthcare professionals. Their core product offerings include innovative surgical instruments and therapeutic devices that aim to enhance patient outcomes and streamline healthcare practices.

These products are engineered to address specific medical challenges, such as improving surgical precision and reducing recovery times for patients. LivsMed targets a diverse clientele, including hospitals, clinics, and specialized medical facilities, primarily within the United States, Japan, and South Korea. The company’s commitment to high-quality manufacturing and adherence to regulatory standards has positioned it as a preferred partner in the healthcare sector, where their products serve a critical role in medical procedures and patient care. LivsMed generated a revenue of KRW 27,143,705,840 in 2024, with an EBITDA of KRW 13,182,658,833.

The company engages in direct sales of its medical devices to healthcare institutions, establishing a robust B2B transaction model. LivsMed maintains long-term partnerships with hospitals and clinics, providing ongoing support and training on product usage, which fosters customer loyalty and repeat business. Transactions typically involve bulk orders of surgical instruments and associated therapeutic products tailored to meet the specific needs of healthcare providers. LivsMed aims to launch several new medical devices in the upcoming year, enhancing its product portfolio.

The company plans to expand into new markets including Southeast Asia and Europe by 2025. The recent KRW 20,000. 00 mn in funding will support these initiatives, enabling LivsMed to bolster research and development efforts and drive market expansion strategies following Kite Entrepreneurship Foundation's complete exit from its stake.